BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 18071041)

  • 1. Chronic pain in Machado-Joseph disease: a frequent and disabling symptom.
    França MC; D'Abreu A; Friedman JH; Nucci A; Lopes-Cendes I
    Arch Neurol; 2007 Dec; 64(12):1767-70. PubMed ID: 18071041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle excitability abnormalities in Machado-Joseph disease.
    França MC; D'Abreu A; Nucci A; Lopes-Cendes I
    Arch Neurol; 2008 Apr; 65(4):525-9. PubMed ID: 18413477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairments in Machado-Joseph disease.
    Kawai Y; Takeda A; Abe Y; Washimi Y; Tanaka F; Sobue G
    Arch Neurol; 2004 Nov; 61(11):1757-60. PubMed ID: 15534186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of ataxia in patients with Machado-Joseph disease.
    França MC; D'Abreu A; Nucci A; Cendes F; Lopes-Cendes I
    Mov Disord; 2009 Jul; 24(9):1387-90. PubMed ID: 19441132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical correlates of autonomic dysfunction in patients with Machado-Joseph disease.
    França MC; D'Abreu A; Nucci A; Lopes-Cendes I
    Acta Neurol Scand; 2010 Jun; 121(6):422-5. PubMed ID: 20070275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive atrophy of cerebellum and brainstem as a function of age and the size of the expanded CAG repeats in the MJD1 gene in Machado-Joseph disease.
    Onodera O; Idezuka J; Igarashi S; Takiyama Y; Endo K; Takano H; Oyake M; Tanaka H; Inuzuka T; Hayashi T; Yuasa T; Ito J; Miyatake T; Tsuji S
    Ann Neurol; 1998 Mar; 43(3):288-96. PubMed ID: 9506544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sleep symptoms and their clinical correlates in Machado-Joseph disease.
    D'Abreu A; França M; Conz L; Friedman JH; Nucci AM; Cendes F; Lopes-Cendes I
    Acta Neurol Scand; 2009 Apr; 119(4):277-80. PubMed ID: 18771522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machado-Joseph disease enhances genetic fitness: a comparison between affected and unaffected women and between MJD and the general population.
    Prestes PR; Saraiva-Pereira ML; Silveira I; Sequeiros J; Jardim LB
    Ann Hum Genet; 2008 Jan; 72(Pt 1):57-64. PubMed ID: 17683516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-movement disorder heralds symptoms of Machado-Joseph disease years before ataxia.
    D'Abreu A; Friedman J; Coskun J
    Mov Disord; 2005 Jun; 20(6):739-41. PubMed ID: 15747372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100B and NSE serum concentrations in Machado Joseph disease.
    Tort AB; Portela LV; Rockenbach IC; Monte TL; Pereira ML; Souza DO; Rieder CR; Jardim LB
    Clin Chim Acta; 2005 Jan; 351(1-2):143-8. PubMed ID: 15563883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pain in multiple sclerosis: a clinical and instrumental approach.
    Grasso MG; Clemenzi A; Tonini A; Pace L; Casillo P; Cuccaro A; Pompa A; Troisi E
    Mult Scler; 2008 May; 14(4):506-13. PubMed ID: 18562505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular genetics of Machado-Joseph disease].
    Kawakami H; Maruyama H; Nakamura S
    Nihon Rinsho; 1996 Mar; 54(3):854-60. PubMed ID: 8904248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopa-responsive parkinsonism phenotype of Machado-Joseph disease: confirmation of 14q CAG expansion.
    Tuite PJ; Rogaeva EA; St George-Hyslop PH; Lang AE
    Ann Neurol; 1995 Oct; 38(4):684-7. PubMed ID: 7574470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use.
    Peniston JH; Gould E
    Clin Ther; 2009 Feb; 31(2):347-59. PubMed ID: 19302907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machado-Joseph shoe.
    Liu CS; Hsieh M; Chen YY; Lo MC
    Mov Disord; 2005 Jan; 20(1):66-8. PubMed ID: 15390034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excessive fragmentary myoclonus in Machado-Joseph disease.
    dos Santos DF; Pedroso JL; Braga-Neto P; Silva GM; de Carvalho LB; Prado LB; Barsottini OG; do Prado GF
    Sleep Med; 2014 Mar; 15(3):355-8. PubMed ID: 24518960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired P50 sensory gating in Machado-Joseph disease.
    Ghisolfi ES; Maegawa GH; Becker J; Zanardo AP; Strimitzer IM; Prokopiuk AS; Pereira ML; Carvalho T; Jardim LB; Lara DR
    Clin Neurophysiol; 2004 Oct; 115(10):2231-5. PubMed ID: 15351363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between trinucleotide repeat length and phenotypic variation in Machado-Joseph disease.
    Matsumura R; Takayanagi T; Fujimoto Y; Murata K; Mano Y; Horikawa H; Chuma T
    J Neurol Sci; 1996 Jul; 139(1):52-7. PubMed ID: 8836972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pain in Parkinson's disease: Prevalence and characteristics.
    Beiske AG; Loge JH; Rønningen A; Svensson E
    Pain; 2009 Jan; 141(1-2):173-7. PubMed ID: 19100686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The international cooperative ataxia rating scale in Machado-Joseph disease. Comparison with the unified multiple system atrophy rating scale.
    D'Abreu A; Franca M; Lopes-Cendes I; Cendes F
    Mov Disord; 2007 Oct; 22(13):1976-9. PubMed ID: 17876849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.